HighTower Advisors’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
MAM
WC
FCM
LG
MCM
AI
IC
HighTower Advisors's STIM Position: Q2 2026 in Review
HighTower Advisors increased its Neuronetics (STIM) stake by 0.24% in Q2 2026, buying an estimated $2K and bringing the position to 563,741 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #2449.
HighTower Advisors first reported a position in STIM in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.58M in Q3 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- HighTower Advisors held 563,741 shares of Neuronetics worth $733K as of Q2 2026.
- HighTower Advisors bought 1,371 Neuronetics shares in Q2 2026, an estimated $2K.
- Neuronetics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2449 holding.
- HighTower Advisors first reported a position in Neuronetics in Q3 2020 and has held it in 24 quarters since.
- HighTower Advisors's Neuronetics position peaked at $1.58M in Q3 2025.
- 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.